FIBROGEN INC (FGEN) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 2013 - 2023
Historical data
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
-
Summary
-
Fibrogen Inc annual/quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from 2013 to 2023.
- Fibrogen Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending June 30, 2021 was -$135 M, a 58% decline year-over-year.
- Fibrogen Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending June 30, 2021 was -$231 M, a 25.8% increase year-over-year.
- Fibrogen Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was -$287 M, a 2.71% increase from 2022.
- Fibrogen Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was -$295 M, a 1.44% decline from 2021.
- Fibrogen Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was -$291 M, a 54% decline from 2020.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Growth (%)